Brian Mo is a Senior Research Scientist at Novonesis, a position held since January 2024 following the merger of Novozymes and Chr. Hansen. Prior to this role, Brian worked at Novozymes from April 2021 to January 2024 as a Senior Scientist and Research Scientist, focusing on microbial strain engineering for cost-effective biofuel-related enzyme production, developing Python-based bioinformatics tools for rapid microbial strain genotyping, and creating high-throughput CRISPR-mediated genome editing workflows. Brian holds a PhD and MSc in Applied Microbiology from Kyoto University, earned between 2016 and 2021, and a Bachelor of Science in Biotechnology from the University of Melbourne, completed in 2014.
This person is not in the org chart
This person is not in any teams
This person is not in any offices